Novartis AG Expense Due To Unwinding Of Discount On Provisions
Novartis AG (NVS) reported Expense Due To Unwinding Of Discount On Provisions of $72.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions · last filed 2026-02-04
| Period end | Expense Due To Unwinding Of Discount On Provisions 12 month | Expense Due To Unwinding Of Discount On Provisions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $72.00M 20-F · filed 2026-02-04 | |
| 2024-12-31 | $68.00M 20-F · filed 2026-02-04 | |
| 2023-12-31 | $66.00M 20-F · filed 2026-02-04 | $63.00M 20-F · filed 2024-01-31 |
| 2022-12-31 | $103.00M 20-F · filed 2025-01-31 | $108.00M 20-F · filed 2023-02-01 |
| 2021-12-31 | $95.00M 20-F · filed 2024-01-31 | $98.00M 20-F · filed 2022-02-02 |
| 2020-12-31 | $94.00M 20-F/A · filed 2023-05-15 | |
| 2019-12-31 | $70.00M 20-F · filed 2022-02-02 | |
| 2018-12-31 | $55.00M 20-F · filed 2021-01-26 | $65.00M 20-F · filed 2019-01-30 |
| 2017-12-31 | $9.00M 20-F · filed 2020-01-29 | $19.00M 6-K · filed 2018-01-24 |
| 2016-12-31 | -$2.00M 20-F · filed 2019-01-30 | |
| 2015-12-31 | -$14.00M 6-K · filed 2018-01-24 |